(October 26, 2016, 1:47 PM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on Oct. 24 said it approved classwide labeling changes for all prescription testosterone products and anabolic androgenic steroids (AAS) to warn about the risk of abuse and dependence....